News Summary: AstraZeneca to cut 1,600 US, UK jobs

News Summary: AstraZeneca restructuring will eliminate 1,600 US, UK jobs, relocate global HQ

Associated Press

R&D REVAMP: Drugmaker AstraZeneca is shifting research and development functions around among several of its sites and spending $500 million to build a new center in Cambridge, England. It's creating three hubs near major research hot spots in the U.S., UK and Sweden.

THE GOAL: The Nexium maker's new CEO, Pascal Soriot, wants to boost research productivity, partly by increasing collaboration with outside scientists, and to lower spending. That's needed because generic competition has been reducing sales and profit.

THE COST: About 1,600 workers will lose their jobs, mainly in Wilmington, Del., elsewhere in the U.S. and in the UK.

Sorry you didn't like this comment. Please provide a reason below.

Are you sure?
Rating failed. Try again.
Request failed. Try again.
We will promote constructive and witty comments to the top, so everyone sees them!
Sorry, we can’t load comments right now. Try again.

    Recommended for You